These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 526874)

  • 21. Diltiazem inhibits halothane-induced contractions in malignant hyperthermia-susceptible muscles in vitro.
    Ilias WK; Williams CH; Fulfer RT; Dozier SE
    Br J Anaesth; 1985 Oct; 57(10):994-6. PubMed ID: 4041327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of propranolol on the in vitro response to caffeine and halothane in malignant hyperthermia-susceptible muscle.
    Ording H
    Acta Anaesthesiol Scand; 1989 Jul; 33(5):405-8. PubMed ID: 2800978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening for malignant hyperthermia susceptibility.
    Anderson IL; Rawstron RE; Dunlop DJ
    N Z Med J; 1980 Jun; 91(661):417-9. PubMed ID: 6930029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diagnosis of susceptibility for malignant hyperthermia using in-vitro muscle contraction testing in Switzerland].
    Urwyler A; Censier K; Seeberger MD; Drewe J; Rothenbühler JM; Frei F
    Schweiz Med Wochenschr; 1991 Apr; 121(16):566-71. PubMed ID: 2042040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The control of muscle contracture by the action of dantrolene on the sarcolemma.
    Halsall PJ; Ellis FR
    Acta Anaesthesiol Scand; 1983 Jun; 27(3):229-32. PubMed ID: 6880584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of chlorocresol vs caffeine on muscle contracture in malignant hyperthermia susceptible patients].
    Ben-Abraham R; Krivosic-Horber RM; Haudcoeur G; Perel A; Adnet PJ
    Harefuah; 1997 Jun; 132(12):839-41, 911. PubMed ID: 9264187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. W-7, a calmodulin antagonist, and contracture of malignant hyperthermia susceptible skeletal muscle.
    Holland M; Williams JH; Lee JC
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1992 Feb; 101(2):383-8. PubMed ID: 1354116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calmodulin-antagonist drugs and porcine malignant hyperpyrexia.
    Collins SP; White MD; Denborough MA
    Clin Exp Pharmacol Physiol; 1988 Jun; 15(6):473-7. PubMed ID: 3271620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Malignant hyperthermia: effects of halothane on the surface membrane.
    Iaizzo PA; Lehmann-Horn F; Taylor SR; Gallant EM
    Muscle Nerve; 1989 Mar; 12(3):178-83. PubMed ID: 2725547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of the calcium agonist BAY K 8644 for in vitro diagnosis of susceptibility to malignant hyperthermia.
    Adnet PJ; Krivosic-Horber RM; Haudecoeur G; Adamantidis MM; Reyford GH; Imbenotte M; Cordonnier C
    Br J Anaesth; 1990 Dec; 65(6):791-5. PubMed ID: 1702303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of halothane, caffeine, dantrolene and tetracaine on the calcium permeability of skeletal sarcoplasmic reticulum of malignant hyperthermic pigs.
    Ohnishi ST
    Biochim Biophys Acta; 1987 Feb; 897(2):261-8. PubMed ID: 2434128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro responses of cat skeletal muscle to halothane and caffeine.
    Deuster PA; Bockman EL; Muldoon SM
    J Appl Physiol (1985); 1985 Feb; 58(2):521-7. PubMed ID: 3980355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ultrasound Elastography for Rapid, Real-time Detection of Localized Muscular Reaction in Malignant Hyperthermia-susceptible Pigs.
    Johannsen S; Türkmeneli I; Isbary S; Roewer N; Schuster F
    Anesthesiology; 2018 Nov; 129(5):989-999. PubMed ID: 30204593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Caffeine and halothane contracture testing in swine using the recommendations of the North American Malignant Hyperthermia Group.
    Allen GC; Fletcher JE; Huggins FJ; Conti PA; Rosenberg H
    Anesthesiology; 1990 Jan; 72(1):71-6. PubMed ID: 2297135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In-vitro contracture testing for susceptibility to malignant hyperthermia: can halothane be replaced?
    Metterlein T; Schuster F; Kranke P; Roewer N; Anetseder M
    Eur J Anaesthesiol; 2011 Apr; 28(4):251-5. PubMed ID: 20827211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro contracture testing for determination of susceptibility to malignant hyperthermia: a methodologic update.
    Iaizzo PA; Wedel DJ; Gallagher WJ
    Mayo Clin Proc; 1991 Oct; 66(10):998-1004. PubMed ID: 1833602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of susceptibility to malignant hyperpyrexia in swine.
    Okumura F; Crocker BD; Denborough MA
    Br J Anaesth; 1979 Mar; 51(3):171-6. PubMed ID: 435338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Static v. dynamic tests in the in vitro diagnosis of malignant hyperthermia susceptibility.
    Ranklev E; Fletcher R; Blomquist S
    Br J Anaesth; 1986 Jun; 58(6):646-8. PubMed ID: 3707802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abnormal membrane properties of the sarcoplasmic reticulum of pigs susceptible to malignant hyperthermia: modes of action of halothane, caffeine, dantrolene, and two other drugs.
    Ohnishi ST; Waring AJ; Fang SR; Horiuchi K; Flick JL; Sadanaga KK; Ohnishi T
    Arch Biochem Biophys; 1986 Jun; 247(2):294-301. PubMed ID: 2424370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of cocaine on the contracture response to 1% halothane in patients undergoing diagnostic muscle biopsy for malignant hyperthermia.
    Sato N; Brum JM; Mitsumoto H; DeBoer GE
    Can J Anaesth; 1995 Feb; 42(2):158-62. PubMed ID: 7720160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.